Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06406049 · ClinicalTrials.gov registry record · NA
Finishing HIV Project
A NA study of HIV, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 624
- Enrollment target
- 1
- Study location
NCT06406049: Recruiting NA study of HIV, sponsored by University of Miami.
NCT06406049 is a NA study of HIV that is actively recruiting participants, run by University of Miami. The registered enrollment target is 624 participants, above the 438-participant average among 303 other HIV trials with a reported enrollment target (42% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06406049, a NA study of HIV, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 624 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to learn how to help enable healthy behaviors and lower the risk of HIV among Latinx Men.
Primary Outcome
PrEP initiation will be measured by analyzing the number of participants that initiate PrEP divided by the total number of participants
Conditions Studied
Interventions
- OTHER Control group
- BEHAVIORAL Social network intervention
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 624 participants |
| Start Date | 2024-11-08 |
| Est. Completion | 2029-11-15 |
| Phase | NA |
What NCT06406049 shows while recruiting
NCT06406049 is an interventional study that assigns participants to a tested intervention. The registered 624 participants enrollment target is mid-sized for trials with a published cap, above the 438-participant average among 303 other HIV trials with a reported enrollment target (42% higher).
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Control group is the first listed.
NCT06406049 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06406049 about?
NCT06406049 is a clinical study titled "Finishing HIV Project". This study aims to learn how to help enable healthy behaviors and lower the risk of HIV among Latinx Men.
What is the current status of trial NCT06406049?
This trial is currently recruiting. It is a NA study. The enrollment target is 624 participants. The study started on 2024-11-08. Estimated completion is 2029-11-15.
What conditions does trial NCT06406049 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT06406049?
The interventions under investigation include: Control group (OTHER), Social network intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06406049?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06406049 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06406049's enrollment target sits among peer trials
624 30th of 303 higher than 274 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05349227 · 625 participants · NA
Comprehensive Outcomes for After Cancer Health
- NCT06103864 · 625 participants · Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- NCT06230510 · 625 participants · NA
Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health
- NCT06677112 · 625 participants · NA
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI